High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Not all low-cost index funds support drip, so compare available options and setup steps to automate reinvestment and maximize growth.
26,805 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Scammers pretending to be regulators are getting more convincing. This guide helps you spot the red flags, verify leg...
A new crackdown targets the cartel’s use of digital money to move profits. Learn how treasury sanctions sinaloa carte...
The Verus bridge exploit ends with a partial recovery: 4,052 ETH returned within 24 hours, leaving a $2.8 million whi...
When your real estate agent goes quiet, you don’t have to wait. This guide shows how to create your own deal flow and...
A wave of AI demand and energy-cost pressures are reviving interest in crypto operators who pivot to AI compute. The ...
A headline-grabbing lawsuit shines a light on pregnancy rights, workplace duties, and the real financial stakes of wo...
A Houston geothermal startup storms Wall Street, delivering the clean energy sector’s largest IPO to date with a $10B...
Investors noticed a notable move in jumia technologies stock jumped this week as Jumia reported improving early resul...
AI growth drives data-center electricity demand, creating opportunities for energy players with long-term contracts. ...
A top AI stock has pulled back while earnings surge, drawing attention from analysts who see significant upside ahead...
Three heavyweight asset managers have pulled back sharply on private credit fears. This piece explains why these fina...